| Name | Preferred Homecare |
|---|---|
| Organization Name | Founders Healthcare, Llc |
| Location | 871 Grier Dr, Ste C, Las Vegas, Nevada 89119 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (702) 951-6900 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The Allergy Centre of the Charité-Universitätsmedizin Berlin will host three international scientific conferences in the upcoming week. According to Prof. Marcus Maurer, Associate Director of the Allergy Centre at the Clinic for Dermatology, Venereology and Allergology: "Allergological issues have been gaining in importance among clinical physicians." Prof. Mauer explains that all three conferences are focused on enabling scientific exchange about basic allergy research: "Our intent is to offer clinical physicians the opportunity to learn something about the cells, the basis for allergological illnesses.
ProChon Biotech, Ltd., an innovator of tissue regenerative technologies that are being developed to relieve pain and restore the mobility and quality of life for sufferers of articular cartilage injuries, today announced a significant expansion of its clinical study of the BioCart™ Cartilage Regeneration System.
In a study of nearly 2,000 adults, researchers found that a buildup of plaque in the body's major arteries was associated with mild cognitive impairment. Results of the study conducted at the University of Texas Southwestern Medical Center will be presented next week at the annual meeting of the Radiological Society of North America.
A group of more than a half dozen CEOs from some of America's largest health care providers on Friday called for an end to fee-for-service payments under Medicare, and for incentives to create administrative efficiencies to lower costs to help pay for America's health care reform.
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that, on June 1, 2010, the Company received a letter from The Nasdaq Stock Market indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, Nile was not in compliance with Marketplace Rule 5550(a)(2).
› Verified 3 days ago
| NPI Number | 1063452829 |
| Organization Name | FOUNDERS HEALTHCARE, LLC |
| Doing Business As | PREFERRED HOMECARE |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 871 Grier Dr Ste C, Las Vegas, NV 89119 |
| Phone Number | 702-951-6900 |
News Archive
The Allergy Centre of the Charité-Universitätsmedizin Berlin will host three international scientific conferences in the upcoming week. According to Prof. Marcus Maurer, Associate Director of the Allergy Centre at the Clinic for Dermatology, Venereology and Allergology: "Allergological issues have been gaining in importance among clinical physicians." Prof. Mauer explains that all three conferences are focused on enabling scientific exchange about basic allergy research: "Our intent is to offer clinical physicians the opportunity to learn something about the cells, the basis for allergological illnesses.
ProChon Biotech, Ltd., an innovator of tissue regenerative technologies that are being developed to relieve pain and restore the mobility and quality of life for sufferers of articular cartilage injuries, today announced a significant expansion of its clinical study of the BioCart™ Cartilage Regeneration System.
In a study of nearly 2,000 adults, researchers found that a buildup of plaque in the body's major arteries was associated with mild cognitive impairment. Results of the study conducted at the University of Texas Southwestern Medical Center will be presented next week at the annual meeting of the Radiological Society of North America.
A group of more than a half dozen CEOs from some of America's largest health care providers on Friday called for an end to fee-for-service payments under Medicare, and for incentives to create administrative efficiencies to lower costs to help pay for America's health care reform.
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that, on June 1, 2010, the Company received a letter from The Nasdaq Stock Market indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, Nile was not in compliance with Marketplace Rule 5550(a)(2).
› Verified 3 days ago
News Archive
The Allergy Centre of the Charité-Universitätsmedizin Berlin will host three international scientific conferences in the upcoming week. According to Prof. Marcus Maurer, Associate Director of the Allergy Centre at the Clinic for Dermatology, Venereology and Allergology: "Allergological issues have been gaining in importance among clinical physicians." Prof. Mauer explains that all three conferences are focused on enabling scientific exchange about basic allergy research: "Our intent is to offer clinical physicians the opportunity to learn something about the cells, the basis for allergological illnesses.
ProChon Biotech, Ltd., an innovator of tissue regenerative technologies that are being developed to relieve pain and restore the mobility and quality of life for sufferers of articular cartilage injuries, today announced a significant expansion of its clinical study of the BioCart™ Cartilage Regeneration System.
In a study of nearly 2,000 adults, researchers found that a buildup of plaque in the body's major arteries was associated with mild cognitive impairment. Results of the study conducted at the University of Texas Southwestern Medical Center will be presented next week at the annual meeting of the Radiological Society of North America.
A group of more than a half dozen CEOs from some of America's largest health care providers on Friday called for an end to fee-for-service payments under Medicare, and for incentives to create administrative efficiencies to lower costs to help pay for America's health care reform.
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that, on June 1, 2010, the Company received a letter from The Nasdaq Stock Market indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, Nile was not in compliance with Marketplace Rule 5550(a)(2).
› Verified 3 days ago
A-class Medical Supplies Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5460 Cameron St, Las Vegas, Nevada 89118 Phone: (702) 462-2247 | |
Accredo Health Group Inc Type: Pharmacy Location: 1335 E Sunset Rd, Las Vegas, Nevada 89119 Phone: (702) 895-8990 | |
Qhr Pharmacy Type: Community/Retail Pharmacy Location: 7512 Westcliff Dr, Las Vegas, Nevada 89145 Phone: (702) 331-6796 | |
Advanced Prosthetics & Orthotics In Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7455 W. Washington Ave, Las Vegas, Nevada 89128 Phone: (702) 256-5265 | |
Aeva Specialty Pharmacy Type: Pharmacy Location: 6280 S Valley View Blvd, Las Vegas, Nevada 89118 Phone: (702) 558-2382 |